Trial Profile
Double Blind, Double Dummy, Randomized, Placebo-controlled, 5 Period Cross-over Study To Examine The Effect Of PF-05089771 Alone And In Combination With Pregabalin On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin And Ibuprofen As Positive Controls
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs PF 5089771 (Primary) ; Ibuprofen; Pregabalin
- Indications Neuropathic pain; Pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 22 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 03 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
- 04 Feb 2015 New trial record